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Abstract. The expression of the cell-cell adhesion
molecules E- and P-cadherin has been analyzed in
seven mouse epidermal keratinocyte cell lines repre-
sentative of different stages of epidermal carcinogene-
sis. An inverse correlation between the amount of
E-cadherin protein and tumorigenicity of the cell lines
has been found, together with a complete absence of
E-cadherin protein and mRNA expression in three car-
cinoma cell lines (the epithelioid HaCa4 and the
fibroblastoid CarB and CarC cells) . A similar result
has been detected in tumors induced in nude mice by
the cell lines, where induction of E-cadherin expres-
sion takes place in moderately differentiated squamous
cell carcinomas induced by HaCa4 cells, although at
much lower levels than in well-differentiated tumors
induced by the epithelial PDV or PDVC57 cell lines.
Complete absence of E-cadherin expression has been
C
ELL adhesion mechanisms play a major role in vital
processes such as embryogenesis, tissue and organ
pattern formation and maintenance of specific tissue
architecture (Edelman, 1985 ; Thiery et al., 1982) . Calcium-
dependent cell-cell adhesion molecules are one ofthe major
components involved in the various processes of intercellular
adhesion (Takeichi et al., 1985). In vertebrates, calcium-
dependent cell-cell adhesion molecules identifiedso far con-
stitute a family of transmembrane glycoproteins, of 119-135
kD, for which the general term cadherins has been proposed
(see Takeichi, 1988, 1990 for reviews) .
The different members of the family, identified in various
tissues and species, can be grouped in three distinct catego-
ries, exemplified in the mouse by (a) N-cadherin (Hatta and
Takeichi, 1986; Hatta et al., 1985), present mostly in neural
tissues ; (b) E-cadherin (identical to uvomorulin) (Yoshida-
Noro et al., 1984; Hyafil et al., 1980; Peyrieras et al., 1985),
expressed in epithelial tissues; and (c) P-cadherin, present
both in epithelialand nonepithelial tissues with major preva-
lence at the placenta (Nose and Takeichi, 1986) . All mem-
bers of the family present strong homology at the amino acid
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observed in spindle cell carcinomas induced by CarB
or CarC cells. P-cadherin protein was detected in all
cell lines that exhibit an epithelial (MCA3D, AT5, PDV,
and PDVC57) or epithelioid (HaCa4) morphology, as
well as in nude mouse tumors, independent of their
tumorigenic capabilities. However, complete absence
of P-cadherin was observed in the fibroblast-like cells
(CarB and CarC) and in spindle cell carcinomas. The
introduction of an exogenous E-cadherin cDNA into
HaCa4 cells, or reactivation of the endogenous
E-cadherin gene, leads to a partial suppression of the
tumorigenicity of this highly malignant cell line. These
results suggest a role for E-cadherin in the progression
to malignancy of mouse epidermal carcinogenesis.
They also suggest that the loss of both E- and P-cad-
herin could be associated to the final stage of carcino-
genesis, the development of spindle cell carcinomas.
level (Nose et al., 1987; Hattaet al., 1988; Ringwald et al.,
1987), but distinct immunological properties and binding
specificities (Nose et al., 1988; Miyatani et al., 1989). The
pattern ofexpression and binding specificities ofthe different
subfamilies are consistent with the proposed role of these
molecules in the segregation of differentiating tissues during
embryogenesis and in the morphogenetic processes involved
in the generation of an organism (Takeichi, 1988, 1990,
1991).
During tumorigenesis, profound alterations in intercellu-
lar and cell-to-substratum interactions take place (for re-
views, see Hynes, 1989 ; Parish et al ., 1987) . Such altera-
tions are particularly evident in tumorigenesis of epithelial
tissues, where the malignant cells have to pass through the
basement membrane barrier in order to invade and metasta-
size other tissues. Even before invading adjacent tissues, the
malignant cellsloosen their adhesion to their original neigh-
bors. The molecular mechanisms underlying such altera-
tions are largely unknown and only recently have begun to
be investigated. Among them, changes in cell-cell interac-
tions mediated by the cadherin family of molecules in rela-
517tion to malignancy have received increasing interest in the
last few years. Studies on tissue sections of various human
carcinomas have shown that E-cadherin is expressed in both
differentiated and dedifferentiated tumors (Eidelman et al.,
1989; Shimoyama et al., 1989), although lowerlevels appear
to be present in poorly differentiated carcinomas (Shimo-
yama et al., 1989) . A recent study on E-cadherin expression
in several human carcinoma cell lines indicates that acquisi-
tion ofthe invasion properties ofdedifferentiated fibroblastoid
carcinoma cells is associated with the loss of E-cadherin ex-
pression (Frixen et al., 1991). These observations, together
with previous similar results with H-ras-transformed MDCK
cells (Behrens et al., 1989), support a role for E-cadherin
as an antiinvasive molecule, and as a marker ofthe differenti-
ation grade of epithelial carcinomas (Frixen et al., 1991) .
The expression of P-cadherinhas so far only been reported
in one study ofhuman epithelial carcinomas (Shimoyama et
al., 1989).
Our laboratory is investigating the role ofE- and P-cadherin
during the tumorigenic process ofmouse epidermal carcino-
genesis. Both cadherins are the only members ofthe calcium
dependent cell-cell adhesion molecules expressed in normal
mouse skin with P-cadherin restricted to the proliferative
basal layer and E-cadherinexpressed in the basal and supra-
basal layers (Nose and Takeichi, 1986). The model of two-
stage mouse skin carcinogenesis is based in the progressive
induction of premalignant papillomas and invasive carci-
nomas by treatment with initiating and promoting chemical
agents (Boutwell, 1974; Hecker, 1978; Hennings et al.,
1985). A variety ofcell lines can be derived from tumors and
by in vitro transformation of primary epidermal cells,
providing the opportunity of an in vitro approach to the
mouse skin carcinogenesis system (for review, see Balmain
and Brown, 1988).
In this study, we have analyzed the expression of P- and
E-cadherinin seven mouse epidermal keratinocyte cell lines,
ranging from immortalized nontumorigenic to highly malig-
nant carcinoma-derived cells, which express morphological
phenotypes in culture of epithelial, epithelioid or fibro-
blastoid cells. All cell lines used in this study have been pre-
viously characterized in regard to their expression of normal
and mutant H-ras alleles (Quintanilla et al., 1986, 1991) and
to their differentiation pattern in relation to cytokeratin ex-
pression (Dfaz-Guerra, M., C. Bauluz, S. Haddow, J. L.
Jorcano, A. Cano, A. Balmain, and M . Quintanilla, manu-
script submitted for publication). An inverse correlation be-
tween the amount of E-cadherin protein present and the
tumorigenicity ofthe different cell lines has been found. This
correlation has been detected both in cell cultures and in
tumors induced by injection of the cell lines in nude mice.
Complete absence of both E- and P-cadherin has been de-
tected in cells and tumors of two spindle carcinoma fibro-
blastoid cell lines, whereas F-cadherin, but not E-cadherin,
was presentin a squamous cell carcinoma line. Furthermore,
we show that a partial suppression of the tumorigenicity can
beobtained by transfection ofE-cadherincDNA intothis lat-
ter, highly malignant epithelioid carcinoma cell line. Our
results suggest that, in mouse epidermal carcinogenesis, the
progressive loss of E-cadherin can contribute to the malig-
nancy of squamous cell carcinomas. On the other hand, the
complete loss of both E- and P-cadherin could also play a
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role in the further progression towards poorly differentiated
spindle cell carcinomas.
Materials andMethods
CellLines and Growth Conditions
Theorigin ofthe mouseepidermal keratinocytecell lines used in the present
study (MCA3D, AT5, PDV, PDVC57, HaCa4, CarB andCarQ is described
elsewhere (Dfaz-Guerra, M., C. Bauluz, S. Haddow, J. L. Jorcano, A.
Cano, A. Balmain, and M. Quintanilla, manuscript submitted for publica-
tion) and is briefly summarized in Thble I. All of the epidermal cell lines
were grown in HAM F-12 medium supplemented with a complete set of
amino acids (Gibco Ltd., Paisley, Scotland), 5 or 10% FCS and the anti-
biotics amphotericin B (2.5 /ig/ml), ampicillin (100 kg/ml), and gentamicin
(32 pg/ml) (Sigma Chemical Co., St. Louis, MO). Mouse 10TV2 fibro-
blasts were cultured in Dulbeccds MEM supplemented with 10% FCS
and antibiotics. Cells were grown at 37°C in a humidified 5% COZ at-
mosphere.
7Mnsfection Procedure
HaCa4cells werecotransfected withthepBATEM-2 (Noseet al., 1988) and
the pSV2neo vectors (Southern and Berg, 1982) by the calcium-phosphate
coprecipitation method essentially as described by Nose et al. (1988).
Transfection with 1 jug of pBATEM-2 and 0.1 ug of pSV2neo was carried
outin Dulbeccds MEM supplemented with 10% FCS. After 18 h, theDNA-
containing medium was replaced by fresh HAM F-12 containing 10% FCS,
and 24 h later selection with 0.4 mg/ml G418 (Gibco Ltd.) was begun.
Resistantcolonies were isolated and tested for E-cadherinexpression by im-
munofluorescence staining and Western immunoblotting. Positive cells
were subcloned and used for further studies. The pBATEM-2 vector was
kindly provided by M Takeichi (University ofKyoto, Kyoto, Japan), and the
pSV2neo vector by J. L. Jorcano (CIEMAT, Madrid, Spain) .
7lumorigenicityAssays in NudeMice
Forthetumorigenicitytest, cells werecollected and washedin PBS andsub-
cutaneously injected in male nu/nu mice, 8-10 wk old. 1 x 106 cells were
used for a single injection. In different experiments, mice were either indi-
vidually injected with the same cell line at three different sites (the two
flanks and the neck) or double injected with distinct cells on the left and
right flanks. Animals were observed for tumor formation and sacrificed
when tumors reached a size of ti 2 cm.
ImmunostainingandHistological Procedures
For immunofluorescent staining, cells were grown to confluence on glass
coverslips and, after washing in PBS containing 2.5 mM CaCIZ (or 2 mm
EGTA), were fixed and permeabilized by the methanol-acetone method.
Coverslips were incubated with the mAb ECCD-2 (11500) or PCD-1 (1/20)
as described (Shirayoshi, 1986; Nose and Thkkeichi, 1986). Goat anti-rat
IgG coupledto rhodamine or fluorescein compounds (Nordic Immunologi-
cals Lab., Tilburg, The Netherlands) were used as second antibodies.
Immunocytochemical staining oftumors with the mAb ECCD-2 (11250)
and PCD-1(1/20) was carried out on frozen tissue. Fresh surgically excised
tumors were embedded in OCT compound, frozen in liquid nitrogen, and
stored at -70°C. Cryostat sections of5-6 pm were immunostained by the
alkaline phosphatase method using biotinylated sheep anti-rat Ig (1/200,
Amersham International, Amersharn, England) and extravidin-alkaline
phosphatase complex (1/250, BioMakor, Rehovot, Israel). The alkaline
phosphatase activity was developed using naphtyl ASMXphosphate as sub-
strate and Fast-Red as the chromogen group (Sigma Chemical Co.). As
negative control, we used ratanti-mouse Ig as the primary antibody. Immu-
nocytochemical stainingofnormalmouse skin showing the specific staining
pattern of both antibodies was used as positive control.
Dilutions ofanti-cadherin antibodies were made in 150 mM NaCl, 10
mM Hepes, pH 7.4, 10 mM CaCIZ (HMF-Ca buffer), containing 1%
(wt/vol) BSA and secondary antibodies in PBS containing preimmune goat
serum (1:50 dilution). The mAb ECCD2 and PCD-1 were a generous gift
of M. Takeichi.
Histological analysis of tumors was carried out on 5-6-pm sections of
paraffin embedded material.
51 8Table L Relationship between E- and P-cadherinLevels and Tumorigenicity ofMouseEpidermal Cells in Nude Mice
Morphology of the cell lines in culture indicated as: Ep, epithelial; E; epithelioid; and F, fibroblastoid.
t Levels of E-cadherin detected in whole cell extracts, quantified from densitometric scans ofthree different sutoradiograms such as that shown in Fig. 4 B, are
indicated as the percentage of the level detected in MCA3D extracts.
ß Levels of P-cadherin in whole cell extracts, quantified from the densitometric scan of the autoradiogram shown in Fig. 4 C, are indicated as the percentage of
the level detected in PDV extracts.
II Relative tumorigenicity, indicated as increasing + symbols, was estimated as a function ofthe latency period to obtain tumors of 1 cm diameter and ofthe num-
ber oftumors inducedper injection site. -, no tumors; t, onetumor in three injection sites with a latency period of 3 mo; ++ to ++++, tumors at all injection
sites with latency periods of: ++, 3 wk, +++, 2 wk, and ++++, 7-9 d. More details of tumorigenicity ofthe cell lines are given in Quintanilla et al., 1991,
and in Diaz-Guerra, M., C. Bauluz, S. Haddow, J. L. Jorcano, A. Cano, A. Balmain, and M. Quintanilla, manuscript submitted for publication.
1 The levels of E-cadherin in PDV and PDVC57 whole cell extracts varied between 15 and 50% and 10 and 20%, respectively, of the level detected in MCD3D
extracts in the different experiments.
Preparation ofCellExtracts and WesternBlotting
Whole-cell extracts, without trypsin treatment, were obtained as follows.
Cells grown to confluence on P-100dishes were washed twicewithHMF-Ca
buffer and lysed in 0.5 ml lysis buffer (100 mM NaCl, 50 mM Tris-HCl,
pH 7.4, 5 mM MgC12, 1% Triton X-100, 0.1% SDS, 0.5% Na-deoxycho-
late, 0.05% NaN3) containing 10 mM CaC12 and a mixture of protease in-
hibitors(2 mMPMSF, 2 mM iodoaceticacid, 2 mM N-ethylmaleimide, and
1% trasylol; SigmaChemical Co.). After centrifugation, supernatants were
collected, adjusted to lx Laemmli sample buffer and fractionated on 10%
PAGE-SDS gels, as described (Laemmli, 1970).
Trypsin treatment of cells, in the presence of 2.5 mM CaC12 or 2 mM
EGTA, was carried out as described (Yoshida-Noro et al., 1984). Cell
pellets were then resuspended in 100 al lysis buffer containing 2.5 mM
CaC12 and the mixture of protease inhibitors and treated as described
above.
Western blot analyses ofthe various cell extracts werecarried out essen-
tially as described (Towbin et al., 1979). Samples containing identical
amounts of total proteins were run on 10% PAGE-SDS gels and transferred
to nitrocellulose paper. After staining with Ponceau Red, the filters were
immunoblotted with the mAb ECCD-2 or PCD-1 as described previously
(Nose and Takeichi, 1986).
Northern andSouthern BlotAnalyses
Total RNA from the different cell lines were isolated by the guanidium-
thiocyanate procedure (Chomczynski and Sacchi, 1987). Denatured RNA
(10 lAg) from each sample were fractionated on 1% agarose gels using
formaldehyde-phosphate buffer (Rave et al., 1979) and transferredto nylon
membranes (Zeta Probe; BioRad, Madrid, Spain) using IOx SSC as de-
scribed (Maniatis et al., 1982). Hybridization to 32P-labeled probes was
carried out in 4x SSC, 5 mM EDTA, 20 mM H2NaPO4, pH 7.0, 1% SDS,
10x Denhardts solution containing denatured salmon sperm DNA (200 pg/
ml) for 20 h at 65°C. Filters were then washed twice in2x SSC, 0.1% SDS
at 65°C for 10 min and twice in O.lx SSC, 0.1% SDS at 65°C for 20 min.
After hybridization to the E-cadherin cDNA probe, the filters were rehy-
bridized with the 0-actin cDNA probe in the same conditions.
DNA from the different cell lines was obtained by conventional methods
(Maniatis et al., 1982). 10 ug of each DNA sample were digested with
BamHI or EcoRl restriction enzymes (Boehringer Mannheim S.A., Barce-
lona, Spain) and fractionated on 0.7 % agarose gels. After blotting to nylon
membranes, hybridization to the 32P-labeled E-cadherin cDNA probe was
performed in a solution of 5x SSPE, 50 mM H2NaPO4, pH 7.4, 10 mM
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sodium pyrophosphate, 0.1% SDS, 2x Denhardt's solution, containing
denatured salmon sperm DNA (200 ug/ml) for 20 h at 65°C. Filters were
washed in 2x SSPE, 0.1% SDS for 10 min at room temperature, followed
by 30 min at 65°C in the same buffer (lx SSPE: 180 mM NaCl, 10 mM
H2NaPO4, 1 mM EDTA, pH 7.0).
Theprobeused forE-cadherin detection was the 0.9-kb BamHI fragment
cut from the pBATEM-2 plasmid, containing coding sequences from
nucleotides 993 to 1920 (Nagafuchi et al., 1987); and for 0-actin, a 0.6-kb
EcoRI-HindID fragment of rat 0-actin cDNA kindly provided by J. G.
Castano (Department of Biochemistry, Universidad Autónoma de Madrid,
Madrid, Spain). Inserts were isolated from plasmids by electrophoresis in
agarose, purified by aGenecleankit(Bio 101 Inc., La Jolla, CA) and labeled
by the random primer method (Feinberg and Vogelstein, 1983).
Results
Identification ofE- andPLCadherin inMouse
EpidermalKeratinocytes
The mAbs ECCD-2 and PCD-1 have been shown to recog-
nize mouse E- and P-cadherin, respectively (Shirayoshi et
al., 1986; Nose and Takeichi,1986) . Using these antibodies,
we have studied the expression of both proteins in seven
mouse epidermal keratinocyte cell lines. These include im-
mortalizednontumorigenic keratinocytes (MCA3D, Kulesz-
Martin et al., 1983), a cell line derived by transfection of the
human 124 H-ras oncogene into MCA3D cell (AT5) (Quin-
tanilla et al., 1991), transformed keratinocytes obtained by
treatment of primary epidermal cells with the carcinogen
DMBA (PDV and PDVC57; Bremner and Balmain, 1990;
Quintanilla et al., 1991) and cell lines derived from carci-
nomas induced in vivo by the HaMSV retrovirus and TPA
(HaCa4; Brown et al ., 1986) or by DMBA/TPA treatment
(CarB and CarC ; Quintanilla et al., 1986).
The cell lines were selected for this study because of their
different tumorigenic capabilities in nude mice, ranging
from non-tumorigenic to highly malignant (see Table I), and
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Cell lines Morphology' Origin
E-cadherint
levels
P-cadherin4
levels
Relativell
tumorigenicity
MCA3D Ep Immortalized 100 30 -
mouse keratinocytes
AT5 Ep MCA3D + Human ras 75 56
PDV Ep Transformed with 301 100 ++
DMBA in vitro
PDVC57 Ep Derived from PDV 151 10 +++
by transplantation
HaCa4 E HaMSV/TPA 0 82 + + + +
carcinoma
CarB F DMBA/TPA 0 0 + + + +
carcinoma
CarC F DMBA/TPA 0 0 + + + +
carcinomaFigure 1 . Immunofluorescent staining of epidermal keratinocyte cell lines with themAb ECCD-2 . The different cell lines were grown to
confluence on glass coverslips and washed in PBS containing 2.5 mM CaC1 2 before and after fixation. Cell lines : (a) MCA3D, (b) ÁT5,
(c) PDV, (d) PDVC57, (e andf) HaCa4, (g and h) CarB. (fand h) Phase-contrast images of Haca4 and CarB cells, respectively. Neither
the epithelioid HaCa4 nor the fibroblastoid CarB cell lines are specifically stained by the anti-E-cadherin antibody. Bar, 30 jum .
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520Figure 2 . Immunofluorescent staining of epidermal keratinocyte cell lines with the monoclonal antibody PCD-1 . Cells were grown to
confluence on glass coverslips and washed in PBS containing 2.5 mM CaC1 2 before and after fixation . Cell lines : (a-d) as in Fig. 1 ; (e
andf) CarB ; (g) HaCa4 ; (h and i) CarC . fand i show phase-contrast images of CarB and CarC cells, respectively. See the positive staining
by PCD-1 mAb at the cell-cell interfaces in HaCa4 cells (g), in contrast to the negative staining by ECCD-2 mAb in this cell line (compare
with Fig . 1 e) . Bar, 30 Am .
because they exhibit different morphological phenotypes in
culture . MCA3D, AT5, PDV, and PDVC57 cells present a
typical epithelial morphology with a cobblestone pattern of
growth ; the HaCa4 cell line, derived from a squamous cell
carcinoma, shows an epithelioid phenotype with cell-cell
contacts observed only at high density culture conditions
(Fig . 1 f) and CarB and CarC cells, derived from two inde-
pendent poorly differentiated spindle cell carcinomas, have
a fibroblastoid shape (Fig . 1 h and Fig . 2, f and i) .
The immunofluorescent staining ofthe cells with the mAb
ECCD-2 showed that the four epithelial cell lines, MCA3D,
AT5, PDV, and PDVC57, were stained at the cell-cell contact
Navarro et al . E-Cadherin andMalignancy in Epidermal Carcinogenesis
regions (Fig . 1, a-d) . However, both the epithelioid HaCa4
and the fibroblastoidCarB cell line did not show any specific
fluorescence with this mAb (Fig . 1, e and g, respectively) .
Similar negative staining was also observed in CarC cells
(not shown) . On the other hand, immunofluorescent staining
with the mAb PCD-1 showed that CarB andCarC cells were
negative (Fig. 2, e and h), whereas all the others, including
HaCa4, were positive (Fig. 2, a-d and g) .
The antigens recognized by themAbECCD-2 and PCD-1
in the epidermal keratinocytes were identified as E- and
P-cadherin, respectively, by several criteria . First, localiza-
tion of the immunofluorescent staining at the cell-cell in-
52 1terfaces was dependent on the existence of established in-
tercellular contacts. The immunofluorescence at the cell
boundaries was observed only in confluent cells (Fig . 1, a-d,
and Fig. 2,a-dandg) or within small colonies in low density
cultures, but was absent at the limits of the islands where
there are no neighboring cells (not shown) . Second, Western
blotting of cell extracts obtained in the presence of calcium
detected one ECCD-2 immunoreactive polypeptide of 124
kD (Fig . 3 A, lane 1, see also Fig . 3 B), and one PCD-1
immunoreactive polypeptide of 119 kD (Fig. 3 C), in agree-
ment with the sizes previously reported for mouse E- and
P-cadherins, respectively (Yoshida-Noro et al ., 1984; Hirano
et al ., 1987 ; Nose and Takeichi, 1986) . And finally, both
polypeptides disappeared when the cells were trypsinized in
the presence ofEGTA (see in Fig. 3 A, lane 2, one example
forECCD-2 detection) ; accordingly, the immunofluorescent
staining disappeared when the cells were pretreated with
EGTA before fixation (not shown) .
TheAmount ofSoluble E-Cadherin Inversely
Correlates with Tumorigenicity ofthe Epidermal
CellLines
The levels ofE- and P-cadherin protein expression were ana-
lyzed in whole cell extracts obtained by solubilization of
confluent cell monolayers in the presence of calcium and
protease inhibitors, as described in Materials and Methods .
Aliquots of each cell extract, containing identical amounts
of total protein, were loaded onto gels and blotted with
ECCD-2 orPCD-1 mAb . The results of a representative ex-
periment are presented in Fig . 3, B andC Table I shows a
quantitative determination of soluble E- and P-cadherin lev-
els compared to the tumorigenic capabilities ofthe cell lines
after injection in nude mice. As can be observed, an inverse
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Figure 3 . Immunoblot detection of ECCD-2
and PCD-1 antigens in mouse epidermal cells .
(A) AT5 cells were trypsinized in the presence
of 2.5 mM CaCIZ (lane 1) or in the presence
of 2 mMEGTA (lane 2) before harvesting and
lysis . (B and C) Whole cell extracts ofthe vari-
ous cell lines were obtained from confluent cell
monolayers, without trypsinization, and in the
presence of 10 mM CaCI Z and protease inhibi-
tors . Cell lysates were loaded on 10% PAGE-
SDS gels at 50 lAg protein/lane, transferred to
nitrocellulose membranes, and detected with
ECCD-2 (A and B) or PCD-1 (C) mAbs . In A,
migration of the molecular mass markers, in
kilodaltons, is indicated on the left . In B and
C, only the significant portion of the gels is
shown ; migration ofthe molecular mass mark-
ers, 116, 97.4, and 66 kD is indicated by small
marks on the right . The estimated molecular
mass, in kilodaltons, of the antigens detected
by both antibodies is indicated in each panel by
arrowheads .
correlation between the amount of solubilized E-cadherin
and tumorigenicity was found . MCA3D and AT5 cells,
which are nontumorigenic and weakly tumorigenic, respec-
tively, contained the highest levels of E-cadherin . The pro-
tein decreased in the moderately tumorigenic PDV and
PDVC57 cell lines and was completely absent in the highly
malignant carcinoma derived cells HaCa4, Carc (Fig . 3 B,
Table I) and CarB (Table I, see also Fig . 1 g) . The mouse
10TI/2 fibroblasts were usedas a negative control . The levels
of E-cadherin protein detected in whole cell extracts from
PDV and PDVC57 cells were surprisingly low, as compared
with the immunofluorescent analysis (see Fig. 1), which
could suggest a stronger association of E-cadherin to cyto-
skeletal components in those cell lines . However, solubiliza-
tion experiments of the E-cadherinprotein with the detergent
NP-40 (Hirano et al ., 1987; Nagafuchi and Tàkeichi, 1988)
showed that the low amountsofE-cadherin detected in whole
cell extracts ofPDV and PDVC57 cells cannot be explained
by such an association . In fact, lower levels of insoluble
E-cadherin and a higher proteolytic sensitivity ofthe soluble
component were detected inPDV and PDVC57, as compared
with MCA3D and AT5 cells (not shown) .
In contrast to the above results, no correlation between the
amount of solubilized P-cadherin protein and tumorigenicity
was found in the cell lines which exhibited an epithelial or
epithelioid morphology (Fig . 3 C, Table I) ; high levels ofthe
protein were detected in MCA3D, ÁI5, PDV, and HaCa4
cells, and lower in PDVC57 cells . However, no P-cadherin
was detected inCarC (Fig. 3 C, Table I) andCarB cell (Table
I), in agreement with the immunofluorescent analysis .
The amount of E-cadherin mRNA in the various cell linesFigure 4. Northern and Southern blot analysis of the keratinocyte cell lines for E-cadherin mRNA expression and genomic organization .
(A) Northern blot containing total cellular RNA (10 hg per lane) from the different cell lines were hybridized with the E-cadherin cDNA
probe (0.9-kb BamHI fragment frompBATEM2 vector) and with a rat ß-actin cDNA probe (0.6-kb EcoRI-HindIII fragment) . Migration
of the E-cadherinmRNA (4.5 kb) and ß-actinmRNA (2.0 kb) are indicated by arrowheads on the left. (B and C) Genomic DNA isolated
from the different cell lines was digested with an excess ofBamHI (B) or EcoRl (C) restriction enzymes and hybridized to the E-cadherin
cDNA probe . Migration of pBR322-EcoRI and X-HindIII markers are indicated between B and C. RNAs (A) and/or DNAs (B and C)
were extracted from : lane 1, CarB ; lane 2, CarC ; lane 3, HaCa4 ; lane 4, PDVC57 ; lane S, PDV; lane 6, AT5 ; and lane 7, MCA3D cells .
The two large fragments, detected exclusively inEcoRI-DNA fromPDV cells (C.5), arise from incompleteDNA digestion ofthis particular
sample . The E-cadherin mRNA is not expressed in the three carcinoma cell lines . Apparently no deletions or rearrangements detected
by BamHI or EcoRl enzymes are observed in the carcinoma cell lines .
was analyzed by Northern blot hybridization using a specific
cDNA probe (see Materials and Methods) . A band of4.5-kb
was detected inAT5, PDV, andPDVC57 cells (Fig . 4 A, lanes
6, 5, and 4, respectively, see also Fig . 7, lane 1, for MCA3D
cells), with similar relative abundance inAT5 andPDV cells
and slightly lower levels in PDVC57 cells . The size of this
mRNA is identical to that previously reported for mouse
E-cadherin mRNA (Nagafuchi et al ., 1987) . None of the
carcinoma-derived cells, CarB, CarC, and HaCa4, contained
detectable levels of thismRNA (Fig. 4 A, lanes 1-3), where-
as they expressed high levels ofthe 2.0-kb ß-actin messenger,
used as an internal control (Fig. 4 B) . This suggested that,
in carcinoma-derived cells, the absence of E-cadherin pro-
tein synthesis might occur at themRNA transcriptional level
(or mRNA stability) and prompted us to study the genomic
integrity of the E-cadherin gene.
It has been clearly established that chromosomal aberra-
tions, involving gross alterations ofDNA sequences such as
deletion, amplification, or translocation, are frequently ob-
served inmouse skin carcinogenesis (Conti et al., 1986 ; Al-
daz et al., 1989) . Genetic changes affecting specific genes,
such as the H-ras oncogene, have also been reported in this
system (Quintanilla et al., 1986 ; Bremner and Balmain,
1990) . To analyze the integrity ofthe E-cadherin gene in the
carcinoma cell lines, we compared the restriction patterns of
DNA isolated from the cells after digestion with BamHI or
EcoRI enzymes by Southern blots. Asshown in Fig . 4 B, the
same BamHI restriction pattern with fragments of approxi-
mately 6 .7, 3.2, and 2 .8 kb, was observed in all cell lines . A
similar result was obtained with EcoRI-digested DNA (Fig.
Navarro et al . E-Cadherin and Malignancy in Epidermal Carcinogenesis
4 C), where only minor differences in the number and the
mobilities of the DNA fragments were observed in the PDV
and PDVC57 cell lines (a single fragment of rv 3.4 kb instead
ofthe two 3.6- and 3.3-kb fragments detected in the other cell
lines ; Fig . 4 C, lanes 4 and 5) . These differences can be ex-
plained by theEcoRl polymorphism for the E-cadherin gene
previously identified in the C57BL/6 mouse strain (Eistetter
et al ., 1988), from which both PDV and PDVC57 cell lines
were derived (Fusenig et al., 1982 ; Bremner and Balmain,
1990 ; Quintanilla et al., 1991) .
These results clearly suggest that the absence of E-cad-
herin expression observed in carcinoma-derived cells cannot
be explained on the basis of large rearrangements or dele-
tions affecting the E-cadherin gene, but rather point to inacti-
vation of gene expression . The latter situation appears to
be true, at least for HaCa4 cells, since reexpression of the
E-cadherin gene takes place in tumors induced by this cell
line (see below) .
Expression ofE- andRCadherin in Nude
Mouse-induced Tumors
When the tumors induced by the cell lines in nude mice were
immunohistochemically stained with themAb ECCD-2, we
observed that certain regions of the tumors induced by
HaCa4 cells were positive for E-cadherin, indicating that ex-
pression of E-cadherin was reactivated in an in vivo environ-
ment . The staining, however, was restricted to the central
differentiated regions and was completely absent from the
highly anaplastic periphery of the tumors (Fig . 5 e) .
The E-cadherin immunostaining pattern of HaCa4 in-
523Figure 5 . Histology andimmunohistological localization of E- and P-cadherin in nude mouse-induced tumors by the epidermal cell lines .
(a-c) PDVinduced tumors ; (df) HaCa4-induced tumors ; (g-i) CarB-induced tumors . (a, d, and g) Histological analysis of paraffin-
embedded material . (b, e, and h) E-cadherin immunostaining . (c, f, and i) P-cadherin immunostaining . E- and P-cadherin were stained
on frozen material with the mAb ECCD-2 and PCD-1, respectively, using a biotin-extravidin-alkaline phosphatase complex. Induction
of E-cadherin expression takes place in reduced areas of tumors induced by HaCa4 cells . Complete absence of E- and P-cadherin was
detected in spindle cell carcinomas induced by CarB cells . Bar, 150 Im .
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524duced tumors was different from that of PDV (Fig. 5 b) and
PDVC57 (not shown) tumors, where E-cadherin appeared
more widely and homogeneously distributed. A semiquan-
titative estimation of E-cadherin staining in the tumor sec-
tions suggests a range of protein expression similar to that
observed in the cultured cell lines with PDV greater than that
of PDVC57 which is much higher than that of HaCa4. In all
of these tumors, classified as squamous cell carcinomas by
histological criteria (see Fig. 5, a and d), E-cadherin im-
munostaining was always detected at the cell-cell contact
areas ofdifferentiating and keratinizing regions and was ab-
sent from the more anaplastic cells (see Fig. 5 e, see also
Fig. 8 b).
On the contrary, immunohistochemical staining of PDV
and HaCa4-tumors with the mAb PCD-1, showed that P-cad-
herin protein was homogeneously distributed throughoutthe
tumor sections and absent from the keratinized areas (Fig.
5, c and f) . Identical results were obtained with PDVC57
tumors (not shown). No differences in PCD-1 staining were
observed in tumors induced by PDV, PDVC57, and HaCa4
cells.
Complete absence of E- and P-cadherin protein expression
was observed in tumors induced by the fibroblast-like CarB
and CarC cells, as exemplified for one CarB-induced tumor
shown in Fig. 5, h and i. Tumors induced by these two cell
lines were classified as spindle cell carcinomas (Fig. 5 g),
in agreement with the origin of both cell lines (Quintanilla
et al., 1986).
Introduction ofExogenous E-Cadherin cDNA into
HaCa4 Cells Confers a More EpithelialPhenotype and
Partially Suppresses Tumorigenicity
To examine whether or not the forced expression of E-cad-
herin could change the tumorigenic potential of carcinoma
cells, we chose the E-cadherin-negative, P-cadherin-posi-
tive, highly malignant HaCa4 cell line.
HaCa4 cells were cotransfected with the pBATEM-2 and
pSV2neo vectors that contain the complete E-cadherincDNA
sequence (Nose etal ., 1988)and a neomycin-resistance gene
(Southern and Berg, 1982), respectively. Neomycin-resistant
colonies were isolated and selection of the E-cadherin-ex-
pressing clones was carried out by immunofluorescence and
Western immunoblotting. Some clones showed a marked
morphological change to a more epithelial phenotype com-
paredto the parental HaCa4 cells. The selected transfectants
were further subcloned by limiting dilution.
Characterization ofthe Tlransfectants
Clones neo3 and neo2 were selected after transfection of
HaCa4 cells with the neomycin-resistance vector alone and
were used as controls in all subsequent analyses. Clone E5
was isolated because, although presenting a HaCa4-like
phenotype and negative immunofluorescent staining with the
mAb ECCD-2, it contained detectable amounts of soluble
E-cadherin by Western blot analysis (not shown) . Subclones
E54 and E58 were further isolated from the E5 clone, and
characterized as E-cadherin positive (E-cad+) and E-cad-
herin negative (E-cadh-), respectively. Subclones E62 and
E24, both E-cad+, were isolated from independent clones.
Fig. 6 shows the morphology and the patterns of E- and
P-cadherin immunofluorescence of various transfectants. As
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can be observed, the E-cad+ transfectants E62 (Fig. 6 d)
and E24 (Fig. 6 g) presented an apparent change in their
morphological phenotype compared with the control neo3
(Fig. 6 a) or the parental HaCa4 cells (see Fig. 1f). Clear
and defined islands with strong intercellular contacts could
easily be observed when the E-cad+ subclones were grown
at low density, in contrast with the behavior of HaCa4 cells.
A similar morphological change was also observed in the
E-cad+ E54 transfectant subclone (not shown). In contrast,
the E-cad- subclone E58 showed the same morphological
phenotype as control cells (Fig. 6 j). Immunofluorescence
analyses of the various cell clones using the mAb ECCD-2
showed that E62, E24 (Fig. 6, e and h) and E54 (not shown)
exhibited positive staining for E-cadherin at the cell-cell
contact areas, whereas clones neo3 and E58 (Fig. 6, b and
k) remained negative as the parental HaCa4 cell line (see
Fig. 1 e) . On the other hand, staining with the mAb PCD-1
showed that all transfectants remained positive for P-cad-
herin (Fig. 6, c, f, i, and l), as expected.
Expression of E-cadherin in the transfectants was further
analyzed by Northern blot hybridization. As shown in Fig.
7 A, one specific band could be detected in the lanes corre-
sponding to the E-cad+ transfectant clones, although at vari-
able intensities. The size of the E-cadherin mRNA detected
in the clones E5, E62, and E54 was -3.9 kb (Fig. 7 A, lanes
3, 4, and S, respectively), smaller than the endogenous
E-cadherinmRNA(4.5 kb), of MCA3Dcells (Fig. 7 A, lane
1, see also Fig. 4 A for the other cell lines). Surprisingly, the
size of the E-cadherinmRNAdetected in clone E24 (4.5 kb)
(Fig. 7 A, lane 2) corresponded to that of the endogenous
mRNA, suggesting that this particular subclone had some-
how switched on the endogenous E-cadherin gene during the
transfection experiment. However, Western blot analysis for
E-cadherin protein revealed that all E-cad+ transfectants
synthesized a 124-kD reactive polypeptide, regardless of the
size of their E-cadherin mRNA (Fig. 7 B, lanes 3-S).
To characterize the genomic integration of the exogenous
cDNA, Southern blot analyses were carried out. As can be
observed in Fig. 7 C, the BamHI patterns of DNA digested
from clones E62, E54, and E5 contained an additional
hybridizing fragment of -0.9 kb, besides the normal 6.7-,
3.2-, and 2 .8-kb fragments (see also Fig. 4 C, for parental
HaCa4 DNA) . The intensity ofthe 0.9-kb fragment was very
weak, although detectable, in DNA from clone E5 (Fig. 7
C, lane 3) and strong in DNA from clones E62 and E54
(Fig. 7 C, lanes 4 and S, respectively). The 0.9-kb band
corresponds exactly to the expected size of the major frag-
ment generated from the exogenous E-cadherincDNA after
BamHI digestion (Nagaf ichi et al., 1987). Thus, the pres-
ence of this fragment is considered as diagnostic of the in-
tegration of the pBATEM-2 vector. This diagnostic 0.9-kb
band was detected neither in DNA from the clones E24, E58,
neo3 (Fig. 7 C, lanes 2, 6, and 7, respectively), nor in that
of the parental HaCa4 cells (see Fig. 4 C, lane 3). An addi-
tional fragment of rv2.7 kb was also detected in the BamHI
pattern of DNA from E62 and E54 subclones (Fig. 7 C, lanes
4 and S), although at lower intensity than the 0.9-kb band .
This 2 .7-kb fragment probably arose from partial digestion
of the cDNA. Similar results were obtained from Southern
blots after EcoRl digestion; a diagnostic band of 2.6 kb was
detected in DNA samples from clones E62, E54, and E5, but
was completely absent in DNA from clones E58, E24, and
neo3 (not shown).
525Figure6 . Morphological phenotypeandimmunofluorescent staining for E- andPcadherin in HaCa4-transfectant cell clones. (a-c) Control
clone HaCaneo3 ; (df) transfectant clone E62 ; (g-i) transfectant cloneE24; (j-1) transfectant clone E58. (a, d, g, andj) Phase-contrast
images of living cells . (6, e, h, and k) Immunofluorescent staining with the mAb ECCD-2 . (c, f, i, and 1) Immunofluorescent staining
with the mAb PCD-I . E-cadherin is expressed at the areas of cell-cell contacts in the E62 and E24 transfectants . Bar, 45 Wm .
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E62, E5, and E54 have stably integrated the exogenous
E-cadherin gene,although atvariable copy numbers. In con-
trast, the subcloneE24didnottakeup the exogenouscDNA,
but activated the endogenous E-cadherin gene, expressing
high levels of E-cadherinmRNAand protein . The subclone
E58 neither integrated theexogenous cDNA nor switched on
theendogenous E-cadherin gene, and its behavior is similar
to that ofthe neo3 clone transfected with the neomycin vec-
tor alone .
Table IL . Size of Tumors in Double-injectedNude Mice*
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Figure 7 . Northern, Western, andSouthern blot
analyses of the HaCa4-transfectant cell clones
for E-cadherin . (A) Northern blot of total cel-
lular RNA (10 Fig per lane) from the different
transfectant cell clones with the E-cadherin
cDNA probe. (B) Western immunoblotting
analysis with the mAb ECCD-2 . (C) BamHI
restriction pattern of DNA samples from the
transfectants for E-cadherin . RNA (A) and
DNA (C) were isolated from : lane 1, control
cell line MCA3D ; lane 2, transfectant clone
E24 ; lane 3, transfectant clone E5 ; lane 4,
transfectant clone E62; lane 5, transfectant
cloneE54; lane 6, transfectant clone E58; and
lane 7, control clone neo3 . (B) Whole cell ex-
tracts obtained in the presence of 10 mM
CaC12 and protease inhibitors from : lane 1,
parental HaCa4 cells ; lane 2, control clone
neo3 ; lane 3, transfectant clone E54 ; lane 4,
transfectant clone E24; lane 5, transfectant
cloneE62 ; and lane 6, transfectant clone E58.
Migration of E-cadherin polypeptide (124 kD)
is indicated by anarrowheadand that ofmolec-
ular mass markers, 205, 116, 97.4, and 66 kD
by small marks on the right . The transfectant
clone E24 has not integrated the exogenous
E-cadherin cDNA, but activated the endoge-
nous E-cadherin gene . All E-cad+ transfec-
tants expressthe same 124-kD immunoreactive
polypeptide .
Tumorigenicity ofthe Ransfectants and Expression of
E-cadherin in NudeMouse-induced Tumors
The tumorigenic capability of the various transfectant cell
lines was tested in nude mice using a double strategy. One
series of mice was double injected as follows: each mouse
received 1 x 106 cells of the control clone neo3 (or neo2)
in the left flankand the same number of cells of each of the
E-cad+ or E-cad- transfectants in the right flank . The
animals were killedwhen tumors in any flankreached a size
* Each mousewas injected with 1 x 101 cells of clone neo3 (or neo2) in the left flank and with the same number of cells of the other cell lines in the right flank.
Animals were sacrificed9-11-dpostinjection, except when indicated, and the excised tumors measured in three dimensions. Data oftumor sizes for each individual
mouse are presented in the same row .
$ The volume of each tumorwas estimated from measures in three dimensions . The volume ratio was established as the ratio between the volume of the tumor
developed on the left flank and the volume of the tumor developed on the right flank.
ß The mouse was sacrificed at day 21 after injection . The estimated latency of tumors were 10 d for neo3 and 12 d for E58 .
II The mouse was sacrificed at day 16 after injection . The estimated latency of tumors were 10 d for neo3 and 15 d for E54 .
Mouse number Cell line Tumor size Cell line Tumor size Volume* ratio
cm
Experiment I
1 neo3 1.5x1.0x1.0 HaCa4 2.0 x 1 .0 x 1 .0 0.75
2 neo2 1.5 x 1 .0 x 0.8 HaCa4 2.0 x 1 .2 x 1 .0 0.5
3 neo3 2 .0 x 1 .0 x 1 .0 ES 2.3x1.0x0.8 0.92
4 neo3 2.0 x 1 .3 x 1.0 E62 0.5 x 0.4 x 0.3 43
5 neo3 2 .0 x 1 .5 x 1 .0 E24 No tumor
Experiment II
1 neo3 1.3 x 1 .0 x 1.0 E58 1 .5 x1 .3 x1 .2 0.55
2 neo3 2.2 x1 .5 x1.4 E58 2.0 x1 .3 x1.1 1 .6ß
3 neo3 1 .5 x 1 .5 x 0.6 E54 0.6 x0.4 x0.3 19
4 neo3 2 .0 x1 .7 x1 .0 E54 1 .1 x0.6 x0.5 10 .311TableIII. Latency and Growth ofTumors in Single-injected Nude Mice
between 1.5 and 2 cm. The results from two experiments are
summarized in TableII. From a total of 10 animals, 8 were
killed at 9-11-d postinjection, and the other 2 animals sur-
vivedfor a longer period of 16 and 21 d. The tumorigenicity
of the control clone neo3 (and neo2) was very close to that
of the parental HaCa4 cells, giving rise to tumors of tit cm
in size within the first 7-9 d. The transfectant cell clones
which were E-cad- (such as E58), or weakly positive (such
as E5) gave rise to tumors with similar latency periods and
growth rates as neo3 or the parental HaCa4 cells. In con-
trast, all of the E-cad+ clones (E62, E54, and E24) gave rise
to tumors with longer latency periods and a slower growth
rate. As can be seen in Table II, all tumors induced by the
control cellsneo3 reached a size at least 10 times larger than
those induced by E-cad+ cells at the killing date.
A second series of mice was individually injected with
each of the different cell clones at three sites. The animals
were examined daily and sacrified when at least two of the
sites developed tumors of -1.5-2 cm. Examples of three
separate experiments are presented in Table III. Parental
HaCa4 cells and E-cad- clones induced armors with very
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* Each mouse was injected subcutaneously with the various cell lines at three sites, the two flanks and the neck (1 x 101 cells per injection site). Animals were
examined daily and the size of tumors was estimated as the higher outer diameter. The estimated size of tumors in the three sites of each individual mouse at
different days after injection is presented.
# Symbols indicate the date on which the mice were killed.
short latency periods and a fast growth rate (the doubling rate
was -2 d) and all animals had to be killed within 9-11-d
postinjection. Animals injected with E-cad+ clones sur-
vived for at least 15 d and, in general, the tumors developed
with longer latency periods and slower growth rates as com-
pared with those induced by E-cad- cells. The data in Table
III (experiments II and III) include two new cell lines
(E24nm and E62nm), derived from nude mouse tumors in-
duced by clones E24 and E62, respectively. As can be ob-
served, both cell lines showed a tumorigenic behavior simi-
lar to that of the parental clones.
A summary of the results of these assays, which includes
the total number of tumors induced by the different clones,
is presented in TableIV A clear-cut difference can be estab-
lished between the tumorigenicity of E-cad- and E-cad+
cells. At least 60% of the tumors induced by E-cad- cells
reached a size of 1 cm between 7 and 9 d after injection. The
remainder of the tumors reached that size at day 11. In con-
trast, all tumors induced by E-cad+ cells developed with
latency periods longer than 10 d, with a variable distribution
between the different transfectants. E62-tumors have shorter
Mouse
number Cell line 7 d 8 d
Size
9 d
of tumors after
11 d
injection day (in centimeters)*
15 d 19 d 21 d 23 d
Expt. I
1 HaCa4 0.5 0.7 1 .0 1 .7t
0.5 0.8 1 .0 2.0
0.2 0.5 0.8 1 .5
2 E5 0.5 1 .0 2 .9
0.2 0.4 0.7
0.2 0.8 1 .2
3 E62 0.3 0.5 0.7 1.0 1 .7t
- 0.2 0.3 0.3 1 .0
_ _ 0.2 0.3 1 .0
4 E24 - 0.1 0.7 1 .0 1 .5t
- 0.1 0.7 1 .0 1 .3
0.1 0.2 0.8 1 .2 1 .5
Expt. II
1 E58 0.3 0.5 0.9 1.2t
0.3 0.4 0.7 1.0
0.5 0.7 1 .0 1 .7
2 E54 - - 0.1 0.2 0.6 1.0 1 .3$
0.1 0.2 0.4 0.6 0.8 1 .2 1.5
- _ 0.2 0.3 0.7 1.1 1 .5
3 E24- - - 1.5 2.Ot
- - 0.1 0.2 1.0 1 .3 1 .6
0.2 0.4 0.4 0.5 1 .0 1.5 1 .7
Expt. III
1 HaCa4 0.4 0.7 1 .0 1.5$
0.4 0.8 1 .0 1 .5
0.5 1 .0 1 .2 1 .7
2 E62 0.3 0.5 0.7 1.0 2.3t
_ _ 0.2 0.4 2.0
0.1 1 .0
3 E62- 0.4 0.6 1 .0 2.0 2.5t
0.2 0.2 0.4 0.5 1 .2Table IV. Summary ofthe Latency ofthe Total Tumors Analyzed
* The total number oftumors induced by the transfectants which reached 1 cm in size (latency) at the indicated days after injection is presented. The figures include
those presented in Tables II and III, and additional data on single-injected animals.
f The + and - symbols represent the relative levels of E-cadherin protein expressed by the different cell lines in culture, derived from immunofluorescence and
Western blotting data.
§ The tumor induced by E62 in a double-injected mouse (neo3/E62) reached a size of 0.5 cm when the mouse was sacrificed 9 d after injection (see Table II,
experiment I, Mouse 4).
II The tumor had reached a size of - 0.2 cm when the mouse was killed 15 d after the injection (see Table III, Experiment III, Mouse 3).
11 The mouse double-injected with neo3/E24 did not develop a tumor on the right flank when it was killed 9 d after the injection (see Table II, Experiment I,
mouse 5) .
latency periods (10-14 d in 60% of the cases) than those in-
duced by E54 cells (15-20 d in 80% ofthe tumors). The most
striking differences were foundwith the E24 clone, which in-
duced tumors with latency periods longer than 20 d and slow
growth rates (see Table III, Expt. 1, mouse 4).
From these experiments, we can conclude that the forced
expression ofE-cadherinleads to a partial suppression of the
tumorigenicity of the highly malignant HaCa4 carcinoma
cell line.
Histological analysis ofthe tumors induced by the different
transfectant cell clones indicated that all were squamous cell
carcinomas (Fig. 8, a, d, and g), as the parental HaCa4 cell
line (see Fig. 5 d) . Immunohistochemical analysis of the
tumors with the mAb ECCD-2 showed that all tumors ex-
pressed E-cadherin at variable levels. Tumors induced by the
control clone neo3 showed a pattern of E-cadherin staining
(Fig. 8 b) very similar to that of HaCa4-induced tumors; a
small number ofE-cadherin expressing cellsrestricted to the
more differentiated and keratinized regions of the tumors.
The same result was obtained in tumors induced by the
E-cad- clone E58 (not shown). Tumors induced by E-cad+
clones, such as E62, showed stronger staining for E-cad-
herin and a more homogeneous distribution throughout the
tumor sections. Most of the cells of E62 tumors, including
the less-differentiated ones, exhibited positive staining at
the cell-cell contact areas, and the intensity of staining in-
creased in the more differentiated and keratinized regions of
the tumor (Fig. 8 e). High levels of E-cadherin expression
were also detected in E24-induced (Fig. 8 h) and E54-in-
duced (not shown) tumors, although in these two cases the
staining appears exclusively localized to the differentiating
regions.
Immunohistochemical staining of the tumors with the
mAb PCD-1 showed that both the intensity and the pattern
ofP-cadherin staining was very similar in all tumors induced
by either E-cad+ or E-cad- transfectant cells. High and ho-
mogeneous expression of P-cadherin was detected in all
regions of the tumors, except in keratinazed areas from
which it was excluded (Fig. 8, c, f, and i) . This is the same
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pattern detected in tumors induced by the parental HaCa4
cells (see Fig. 5 f) .
Discussion
Mouse epidermal carcinogenesis is an invaluable model sys-
tem for the study ofmolecular events associated with tumor
progression. In the present report, we have addressed the
role of calcium dependent cell-cell adhesion molecules in
carcinogenesis by analyzing the expression of E- and P-cad-
herins in a series of mouse epidermal cell lines representa-
tive of different stages of tumor progression and in tumors
induced by injection of cells in nude mice. We have found
an inverse correlation between the levels of solubilized
E-cadherin and the tumorigenicity of the cell lines (Table I).
In addition, a complete absence of E-cadherin protein and
mRNA was observed in the three carcinoma cell lines ana-
lyzed (HaCa4, CarB, and CarC) (see Figs. 1, 3 B, and 4 A).
In contrast, no apparent correlation was detected between
P-cadherin protein levels and tumorigenicity. The highly
tumorigenic HaCa4 cells expressed P-cadherin at even high-
er levels than the nontumorigenic MCA3D. However, P-cad-
herin was absent in two carcinoma cell lines, CarB and CarC
(Figs. 2 and 3 C).
HaCa4 cells derive from a squamous cell carcinoma in-
duced by treatment of mouse skin with the HaMSV retrovi-
rus and TPA (Brown et al ., 1986) ; they present an epithelioid
morphology in culture (Fig. 1 f) and are highly tumorigenic
in nude mice. The CarB and CarC cell lines originated from
two independent, highly malignant spindle cell carcinomas
induced by DMBA/TPA treatment (Quintanilla et al., 1986)
and, consequently, exhibit a fibroblastoid phenotype in cul-
ture (see Fig. 1 h and Fig. 2, fand i). The correlation ob-
served between decreased amounts of E-cadherin protein
and the tumorigenicity ofthe cells, together with the finding
that E-cadherin expression is absent from cultured carci-
noma cells, suggest a role for this cell-cell adhesion mole-
cule in the progression to malignancy of mouse epidermal
carcinogenesis.
529
Cell
line
E-cadherin$
expression 7-9 d
Latency to reach
10-14 d
1 cm in size
15-20 d >20 d
Total number
tumors (injection sites)
Number
of mice
HaCa4 - 7 1 8(8) 4
neo3 - 5 3 8(8) 8
E5 f 3 1 4(4) 2
E58 - 3 2 5(5) 3
E54 +++ 4 1 5(5) 3
E62 + + + 6§ 4 10(10) 4
E62_ + + + 5 1 II 6(6) 2
E24 + + 3 3(4)1 2
E24_ + + 5 1 6(6) 2Figure 8 . Histology and immunohistochemical localization of E- and P-cadherin in nude mouse-induced tumors by HaCa4-transfectant
cell clones . (a-c)Tumors induced by control cloneneo3 ; (df) tumors induced by clone E62 ; (g-i) tumors induced by clone E24 . Immuno-
staining for E- and P-cadherin was carried out as in Fig . 5 . (a, d, and g) Histological analysis of paraffin-embedded material . (b, e, and
h) E-cadherin staining . (c, f, and i), P-cadherin staining . Bar, 150 tm .
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is a possible role for E- and Rcadherin in the maintenance
of cell shape. All the epidermal cells which express both
E- and Rcadherin (MCA3D, AT5, PDV, and PDVC57) ex-
hibit a typical epithelial morphology with a cobblestone
pattern of growth, and express high amounts of cytokeratin
(Dfaz-Guerra, M., C. Bauluz, S. Haddow, J. L. Jorcano, A.
Cano, A. Balmain, and M . Quintanilla, manuscript submit-
ted for publication). Switching off the expression of both
cadherins correlates with a fibroblastoid morphology and
with a highly malignant behavior, exemplified by the CarB
and CarC cell lines. The HaCa4cellsrepresent an intermedi-
ate stage, with tumorigenic properties of carcinoma cells
related to the absence of E-cadherin, but exhibiting an
epithelioid morphology which can be explained by the high
amounts of Rcadherin expressed.
These results are, in principle, in agreement with recent
reports which suggest an anti-invasive role for E-cadherin
(Behrens et al ., 1989; Frixen et al., 1991). However, in those
studies with H-ras-transformed MDCK cells (Behrens et al.,
1989) and with human carcinoma cell lines (Frixen et al.,
1991), a direct correlation between the loss of E-cadherinex-
pression and acquisition of an invasive fibroblastoid pheno-
type has been reported. We show here that this is not always
the case and that, at least in epidermal cells, the phenotypic
epithelioid-fibroblastoid conversion appears to be related
with the loss of both E- and P-cadherin.
The analyses of E-cadherin gene organization in the
epidermal cell lines by Southern blot hybridization suggest
that E-cadherin gene inactivation in mouse carcinoma cells
(see Fig. 4, B and C) can be explained at the transcriptional
level (or mRNA stability) as reported by Frixen et al. (1991)
in human carcinoma cells. We have also found support for
this hypothesisfrom our studies on E-cadherin expression in
nude mouse tumors induced by these cell lines. Immuno-
histochemical staining of tumor sections with the mAb
ECCD-2 showed that reexpression ofE-cadherintakes place
in reduced areas of the tumors induced by HaCa4 cells.
These observations support the existence ofa transcriptional
block in cultured HaCa4 cells and that the E-cadherin gene
can be activated in an in vivo environment.
However, when the relative levels of E-cadherin protein
were compared in stained sections of different tumors, we
observed the same inverse correlation as in cultured cells.
Thus, the overall levels ofE-cadherinprotein were relatively
high and homogeneous in well-differentiated squamous cell
carcinomas induced by PDV and PDVC57 cells and de-
creased in the moderately differentiated squamous cell carci-
nomas induced by HaCa4 cells (compare in Fig. 5, b and e).
In all the squamous cell carcinomas analyzed, E-cadherin
staining was located at the cell-cell contact regions of
differentiating cells, reproducing the expressionpattern ob-
served in normal epidermis (Nose and Takeichi, 1986) . In
addition, poorly differentiated spindle cell carcinomas in-
duced by the CarB and CarC cell lines were completely
negative for both E- and Rcadherin staining (Fig. 5, h and
i ). These observations suggest that instability, or even the
complete switching off, of E-cadherin expression can be as-
sociated with progression to malignancy. In agreement with
our results, low and unstable expression of E-cadherin has
also recently been reported to occurin highly metastatic de-
rivatives of a murine ovarian carcinoma cell line (Hashimoto
Navarro et al. E-Cadherin and Malignancy in Epidermal Carcinogenesis
et al., 1989). However, it is presently unknown if such insta-
bility is the consequence ofalterations of specific transcrip-
tional factors or due to posttranscriptional mechanisms lead-
ing to downregulation of the protein.
We have examined the influence of E-cadherin on the
tumorigenic potential of carcinoma cells by introducing an
exogenous E-cadherin cDNA into the HaCa4cell line. E-cad+
HaCa4 transfectants showed a partial suppression of the
tumorigenicity, giving rise to tumors with longer latency
periods and a higher differentiation grade compared with the
parental HaCa4 cells or control cellstransfected with a neo-
mycin resistance vector alone. Interestingly, the most no-
ticeable effect in the suppression of tumorigenicity was ob-
served in the transfectant E24, which has not incorporated
the exogenous E-cadherincDNA, but, for unknown reasons,
has switched on its endogenous E-cadheringene (see Fig. 7,
A and C, lanes 2). One possible explanation for this behavior
could reside in a higher stability and/or stronger association
to the cytoskeleton of the endogenous versus the exogenous
protein. We are presently investigating this point in greater
detail .
The mouse skin carcinogenesis model is being exhaus-
tively studied in several laboratories to elucidate the molecu-
lar events associated with tumor development and progres-
sion. Activation of the H-ras protooncogene is a frequent
event at the initiation stage induced by DMBA (Quintanilla
et al., 1986 ; Brown et al., 1990), but this activation is not
sufficient to confer a full neoplastic phenotype on the initi-
ated cells (Quintanilla et al., 1991). Although further changes
in the H-ras gene locus can influence tumor progression
(Bremner and Balmain, 1990), other genetic events other
than ras remain to be discovered. Thus, the inactivation of
tumor suppressor genes has been proposed to occur during
progression from papillomas to carcinomas (Bremner and
Balmain, 1990; Bianchi et al., 1990). All cell lines used in
the present study, except the nontumorigenic MCA3D cells,
bore different alterations in the H-ras gene (Quintanilla et
al., 1986, 1991; Bremner and Balmain, 1990) . In contrast
to the results reported for MDCK cells (Behrens et al.,
1989), we show here that transfection of a H-ras oncogene
into MCD3D cells does not confer a fibroblastoid phenotype
nor inactivates E-cadherin expression. In fact, the transfec-
tants, as exemplified here by AT5 cells, remain epithelial,
contain high amounts of E-cadherin, and are weakly tumori-
genic in nude mice. Another example is provided by the cell
line PDV and its derivative PDVC57 in which an increase in
the H-ras mutant gene and p21 mutated product occur in
PDVC57 cells (Bremner and Balmain, 1990; Quintanilla et
al., 1991) . However, both cell lines remain epithelial and
contain detectable amounts ofE-cadherinprotein. These ob-
servations imply that activation of the H-ras protooncogene
in this system is not sufficient for switching off E-cadherin
expression. Although a possible influence of H-ras altera-
tions on the stability of the protein cannot be presently dis-
carded, further molecular events associated with progres-
sion of malignancy could account for the deregulation of
E-cadherin expression in carcinoma cells.
Recent studies in mouse skin carcinogenesis indicate that
loss of heterozygosity of chromosome 7, where the H-ras
gene is located, is a frequent event in the finalstages oftumor
progression (Aldaz et al ., 1989; Bremner and Balmain,
1990; Bianchi et al., 1990). These observations support the
531existence of a putative tumor suppressor gene on chromo-
some 7, linked to the H-ras gene locus, involved in mouse
epidermal carcinogenesis. The relevance of this suggestion
relies in the factthat chromosome 7 is the murine homologue
to human chromosome 11 where at least two putative tumor
suppressor genes are located (Koufos et al., 1989; Haber et
al., 1990) . The results reported here suggest that the putative
murine tumor suppressor gene couldbe involved in the regu-
lation of the differentiation stateofthe epidermal cells. Such
a differentiation gene may regulate, directly or indirectly, the
expression of E- and P-cadherins, as well as other epithelial
markers such as the cytokeratins. In this sense, the progres-
sion from squamous cell carcinomas to spindle cell carci-
nomas, considered the final stage of tumor progression in
mouse epidermal carcinogenesis, involves the progressive
loss of cytokeratins (Klein-Szanto et al., 1989) together with
the suppression ofE- and P-cadherin expression (thispaper) .
For instance, the CarB and CarC cell lines still express mi-
nor amounts of cytokeratins, including the simple epithelial
cytokeratin CK8, a characteristic of transformed epidermal
cell lines (Díaz-Guerra, M., C. Bauluz, S. Haddow, J. L.
Jorcano, A. Cano, A . Balmain, and M . Quintanilla, manu-
script submitted for publication) .
The possible involvement ofP-cadherin, together with that
of E-cadherin, in the final stage of epidermal carcinogenesis
is presently being investigated by transfection of CarB cells
with E- and/or P-cadherin cDNAs.
We thank Amalia Mottles for technical assistance with the cell cultures and
Josefa Durán and Pilar Ocafia for technical assistance with the itmnuno-
histochemical study. We are also grateful to Dr. A. Balmain for the cell
lines and helpful suggestions and to Dr. M. Takeichi for his generous gift
of the mAbs ECCD-2 and PCD-1 and the pBATEM-2 vector.
This work was supportedby the DGICYT (research grant PM88-0004) .
P. Navarro is a predoctoral fellow of the Spanish Ministry of Education.
M . G6mez is a predoctoral fellow of the Autonomous Community of
Madrid.
Received for publication 28 May 1991 and in revised form 3 June 1991 .
References
Aldaz, C. M., D. Trono, F. Larcher, T. J. Slaga, and C. l . Conti. 1989. Se-
quential trisomization ofchromosomes 6 and 7 in mouse skin premalignant
lesions. Mol. Carcinogenesis. 2:22-26.
Balmain, A., and K. Brown. 1988. Oncogene activation in chemical carcino-
genesis. Adv. Cancer Res. 51 :147-182.
Behrens, J., M. M. Mareel, F. M. VanRoy, andW. Birchmeier. 1989. Dissect-
ing tumor cell invasion: epithelial cells acquire invasive properties after the
loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 108:2435-
2447.
Bianchi, A. B., C. M. Aldaz, and C. J. Conti. 1990. Nonrandom duplication
ofthe chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors.
Proc. Nati. Acad. Sci. USA. 87:6902-6906.
Boutwell,R. K. 1974. Thefunction and mechanismofpromoters ofcarcinogen-
esis. CRC Crit. Rev. Toxicol. 2:419-431 .
Bremner, R., and A. Balmain. 1990. Genetic changes in skin tumor progres-
sion: correlationbetween presence ofamutant ras gene and loss ofheterozy-
gosity on mouse chromosome 7. Cell. 61 :407-417.
Brown, K., M. Quintanilla, M. Ramsden, I. B. Keff, S. Young, and A. Bal-
main. 1986. v-ras genes from Harvey and BALB murine sarcomavirusescan
act as initiators oftwo-stage mouse skin carcinogenesis. Cell. 46:447-456.
Brown, K., A. Buchmann, and A. Balmain. 1990. Carcinogen-induced muta-
tions in the mouse c-Ha-ras gene provide evidence of multiple pathways for
tumor progression. Proc. Nati. Acad. Sci. USA. 87:538-542.
Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation
by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Bio-
chem. 162:156-159.
Conti, C. J., C. M . Aldaz, J. O'Connell, A. J. Klein-Sanzto, and T. J. Slaga.
1986. Aneuploidy, an early event in mouse skin tumor development. Car-
cinogenesis. 7:1845-1848.
The Journal of Cell Biology, Volume 115, 1991
Edelman, G. M. 1985 . Cell adhesion and the molecular processes of morpho-
genesis. Annu. Rev. Biochem. 54:135-169.
Eidelman, S ., C. H . Damsky,M. J. Wheelock, andI. Damjanov. 1989. Expres-
sion of cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human
tissues and tumors. Am. J. Pathol. 15:101-110.
Eistetter, H. R., S. Adolph, M. Ringwald, D. Simon-Chazottes; R. Schuh,
J. L. Guénet, and R. Kemler. 1988. Chromosomal mapping of the structural
gene coding for the mouse cell adhesion molecule uvomorulin. Proc. Nail.
Acad. Sci. USA. 85:3489-3493.
Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA
restriction endonuclease fragments to high specific activity. Anal. Biochem.
132:6-13.
Frixen, U. H., J. Behrens, M. Sachs, G. Eberle, B. Voss, A. Warda, D. L6ch-
ner, and W. Birchmeir. 1991 . E-cadherin-mediated cell-cell adhesion pre-
vents invasiveness of human carcinoma cells. J. Cell Biol. 113:173-185.
Fusenig, N. E., D. Breitkreutz, R. T. Dzarlieva, P. Boukamp, E. Herzmann,
A. Bohnert, J. P6hlmann, C. Rausch, S. Schütz, and J. Hornung. 1982.
Epidermal cell differentiation and malignant transformation in culture. Can-
cer Forum. 6:209-240.
Harber, D. A., A . J. Buckler, T. Glaser, K. M. Call, J . Pelletier, R. L. Sohn,
E. C. Douglas, and D. E. Housman. 1990. An internal deletion within an
l Ip13zinc finger gene contributes tothe development ofWilm's tumor. Cell.
61 :1257-1269.
Hashimoto, M., O. Niwa, Y. Nitta, M. Takeichi, and K. Yokoro. 1989. Unsta-
ble expression ofE-cadherin adhesion molecules in metastatic ovariantumor
cells. Jpn. J. Cancer Res. 80:459-463.
Hatta, K., and M. Takeichi . 1986. Expression ofN-cadherin adhesion molecule
associated with early morphogenetic events in chick development. Nature
(Lond.). 320:447-449.
Hatta, K., T. S. Okada, andM. Takeichi. 1985 . A monoclonal antibody disrupt-
ing calcium-dependent cell-cell adhesion of brain tissues: possible role of its
target antigen in animal pattern formation. Proc. Natl. Acad. Sci. USA.
82:2789-2793.
Hatta, K., A. Nose, A. Nagafuchi, and M. Takeichi. 1988. Cloning andexpres-
sion ofcDNA encoding a neural calcium-dependent cell adhesion molecule:
its identity in the cadherin gene family. J. Cell Biol. 106:873-881 .
Hecker, E. 1978. Structure-activity relationships in diterpeneesters irritant and
co-carcinogenic to mouse skin. In Carcinogenesis. Vol. 2. Mechanisms of
Tumor Promotion and Co-carcinogenesis. T. J. Slaga, A. Sivak, and R. K.
Boutwell, editors. Raven Press, New York. 11-48.
Henninngs, H., R. Shores, P. Mitchell, E. F. Spangler, and S. H. Yuspa. 1985.
Inductionofpapillomas with a high probability ofconversion to malignancy.
Carcinogenesis. 6:1607-1610.
Hirano, S., A. Nose, K. Hatta, A. Kawakami, and M. Takeichi. 1987. Cal-
cium-dependent cell-cell adhesion molecules (cadherins): subclass specifici-
ties andpossible involvement ofactinbundles. J. CellBiol. 105:2501-2510.
Hyafil, F., D. Morello, C. Babinet, and F. Jacob. 1980. A cell surface glyco-
protein involved in the compaction ofembryonic carcinoma cells and cleav-
age stage embryos. Cell. 21 :927-934.
Hynes, R. O. 1989. Oncogenic transformation. In Fibronectins . A. Rich, edi-
tor. Springer-Verlag, New York. 301-334.
Klein-Szanto, A. J. P., F. Larcher, R. D. Bonfil, and C. J. Conti. 1989. Mul-
tistage chemical carcinogenesis protocols producespindle cell carcinomas of
the mouse skin. Carcinogenesis. 10:2169-2172 .
Koufos, A., P. Grundy, K. Morgan, K. A. Aleck, T. Hadro, B. C. Lampkin,
A. Kalbakji, and W. K. Cavenee. 1989. Familial Wiedemann-Beckwith syn-
drome and a second Wilm's tumorlocus mapto llp15.5. Am. J. Hum. Genet.
44:711-719.
Kulesz-Martin, M., A. E. Kilkenny, K. A. Holbrook, V. Digernes, and S. H.
Yuspa. 1983 . Properties of carcinogen altered mouse epidermal cells resis-
tant to calcium induced terminal differentiation. Carcinogenesis. 4:1367-
1377.
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of
the head of bacteriophage T4. Nature (Lond.) . 227:680-685.
Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a labo-
ratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
Miyatani, S., K. Shimamura, M. Hatta, A. Nagafuchi, A. Nose, M . Mat-
sunaga, K. Hatta, and M. Takeichi. 1989. Neural cadherin: Role in selective
cell-cell adhesion. Science (Wash. DC). 245:631-635.
Nagafuchi, A., and M. Takeichi. 1988. Cell binding function of E-cadherin is
regulated by the cytoplasmic domain. EMBO (Eur. Mol. Biol. Organ.) J. 7 :
3679-3684.
Nagafuchi, A., Y. Shirayoshi, K. Okazaki, K. Yasuda, and M. Takeichi. 1987 .
Transformation ofcell adhesion properties by exogenously introduced E-cad-
herin cDNA. Nature (Lond.). 329:341-343.
Nose, A., and M. Takeichi. 1986. A novel cadherin adhesion molecule: its ex-
pression patterns associated with implantation and organogenesis of mouse
embryos. J. Cell Biol. 103:2649-2658.
Nose, A., A. Nagafuchi, and M. Takeichi. 1987. Isolationofplacental cadherin
cDNA: identificationofa novel gene family for cell-cell adhesion molecules.
EMBO (Eur. Mol. Biol. Organ.) J. 6:3655-3661 .
Nose, A., A. Nagafuchi, and M . Takeichi. 1988. Expressed recombinant
cadherins mediate cell sorting in model systems. Cell. 54:993-1001 .
Parish, R. W., C. Schmidhauser, T. Schmidt, and R. Dudler. 1987 . Mecha-
nisms of rumour cell metastasis. J. Cell Sci. Suppl. 8:181-197.
532Peyrieras, N., D. Louvard, and F. Jacob. 1985. Characterization of antigens
recognized by monoclonal antibodies and polyclonal antibodies directed
against uvomorulin. Proc. Natl. Acad. Sci. USA. 82:8067-8071 .
Quintanilla, M., K. Brown, M. Ramsden, and A. Balmain. 1986. Carcinogen-
specific mutationand amplification ofHa-rasduring mouse skin carcinogen-
esis. Nature (Zond.). 322:78-80.
Quintanilla, M., S. Haddow, D. Jonas, D. Jaffe, G. T. Bowden, and A. Bal-
main. 1991. Comparison of ras activation during epidermal carcinogenesis
in vitro and in vivo. Carcinogenesis . In press.
Rave, N., R. Crvenjacov, and H. Baedfker. 1979. Identification of procollagen
mRNAs transferred to diazobenzylomethyl paper from formaldehyde aga-
rose gels. Nucleic Acids Res. 11:3559-3567.
Ringwald, M., R. Schuh, D. Vestweber, H. Eistetter, F. Lottpeisch, J. Engel,
R. Dolz, F. Jahnig, J. Epplen, S. Mayer, C. Muller, and R. Kemler. 1987.
The structure ofcell adhesion moleculeuvomorulin. Insights intothe molec-
ular mechanism of Ca'-dependent adhesion. EMBO (Eur. Mot. Biol. Or-
gan.) J. 6:3647-3653 .
Shimoyama, Y., S. Hirohashi, S. Hirano, M. Noguchi, Y. Shimosato, M .
Takeichi, andO. Abe. 1989. Cadherin cell-adhesion molecules in human ep-
ithelial tissues and carcinomas. Cancer Res. 49:2128-2133.
Shirayoshi, Y., T. S. Okada, and M . Takeichi. 1986. N-linkedoligosaccharides
are not involved in the function of a cell-cell binding glycoprotein E-cad-
herin. Cell Struct. Funct. 11:245-252.
Navarro et al, E-Cadherin andMalignancy in Epidermal Carcinogenesis
Southern, P. J., and P. Berg. 1982 . Transformation of mammalian cells to an-
tibiotic resistance with a bacterial gene under the control of the SV40 early
region promoter. J. Mot. Appl. Genet. 1 :327-341.
Takeichi, M. 1988. Thecadherins: cell-cell adhesionmoleculescontrolling ani-
mal morphogenesis. Development (Comb.). 102:639-655.
Takeichi, M. 1990. Cadherins: a molecular family important in selective cell-
cell adhesion. Annu. Rev. Biochem. 59:237-252.
Takeichi, M. 1991 . Cadherin cell adhesion receptors as a morphogenetic regu-
lator. Science (Wash. DC). 251:1451-1455.
Takeichi, M., C. Y. Noro, Y. Shirayoshi, and K. Hatta. 1985 . Calcium-
dependent cell adhesion system: its molecularnature, cell type specificity and
morphogenetic role. In The Cell in Contact. G. M. Edelman and J. P.
Thiery, editors. John Wiley & Sons, Inc., New York. 219-232.
Thiery, J. P., J. L. Duband, U. Rutishauser, and G. M. Edelman. 1982. Cell
adhesion molecules in early chicken embryogenesis. Proc. Natl. Acad. Sci.
USA. 79:6737-6741 .
Towbin, H., T. Staehelin, andJ. Gordon. 1979. Electrophoretic transfer ofpro-
teins from polyacrylanride gels to nitrocellulose sheets: procedure and some
applications. Proc. Nati. Acad. Sci. USA. 82:4683-4687.
Yoshida-Noro, C., N. Suzuki, and M. Takeichi. 1984. Molecularnature ofthe
calcium-dependent cell-cell adhesion system in mouse teratocarcinoma and
embryonic cells studied with a monoclonal antibody. Dev. Biol. 101 :19-27.
533